Goldman Sachs Group (GS)
941.74
+15.79 (1.71%)
NYSE · Last Trade: Apr 21st, 12:34 AM EDT
Detailed Quote
| Previous Close | 925.95 |
|---|---|
| Open | 923.68 |
| Bid | 942.01 |
| Ask | 944.16 |
| Day's Range | 922.99 - 941.80 |
| 52 Week Range | 494.68 - 984.70 |
| Volume | 2,374,273 |
| Market Cap | 323.44B |
| PE Ratio (TTM) | 18.37 |
| EPS (TTM) | 51.3 |
| Dividend & Yield | 16.00 (1.70%) |
| 1 Month Average Volume | 2,135,875 |
Chart
About Goldman Sachs Group (GS)
Goldman Sachs Group is a leading global investment banking, securities, and investment management firm that provides a wide range of financial services to a diverse client base, including corporations, financial institutions, governments, and individuals. The company engages in various activities, including financial advisory services, underwriting of capital market transactions, asset management, and market making in securities and commodities. It is known for its expertise in mergers and acquisitions, risk management, and investment strategy, leveraging its extensive research capabilities and global reach to deliver innovative solutions in an ever-evolving financial landscape. Read More
News & Press Releases
Financial services firm Raymond James Financial (NYSE:RJF) will be announcing earnings results this Wednesday after market close. Here’s what investors shoul...
Via StockStory · April 20, 2026
If a data center is being built, look at what company is providing the energy to power it.
Via The Motley Fool · April 20, 2026
The S&P 500 has soared past 7,000 for the first time. Our team reflects on the market’s rapid rebound and dissects the financial reports we’ve received so far.
Via The Motley Fool · April 20, 2026
The lead crypto is starting to turn a corner, but it is too soon to call it a recovery.
Via The Motley Fool · April 20, 2026
Explore how the underlying bond mix and risk profiles of these ETFs can shape your fixed income strategy in today’s market.
Via The Motley Fool · April 20, 2026
With this new ETF, buying Bitcoin has never been easier or cheaper.
Via The Motley Fool · April 20, 2026
Goldman Sachs expects gold to outperform the U.S. stock market over the next 12 months.
Via The Motley Fool · April 20, 2026
Goldman Sachs’ first quarter saw revenue and profit figures surpass Wall Street’s expectations, yet the market response was negative, reflecting investor cau...
Via StockStory · April 20, 2026
Electronic brokerage firm Interactive Brokers (NASDAQ:IBKR) will be announcing earnings results this Tuesday after market close. Here’s what to expect. Inter...
Via StockStory · April 19, 2026
Explore how differences in portfolio focus and risk profiles set these two core bond ETFs apart for income-minded investors.
Via The Motley Fool · April 19, 2026
AMD and Oracle are important players in the AI infrastructure space, and they are likely to clock impressive earnings growth through the end of the decade.
Via The Motley Fool · April 19, 2026
Can Palantir really nearly triple from here within a few years?
Via The Motley Fool · April 18, 2026
In this episode, Fool contributors discuss recent financial results from banking giants Bank of America and Charles Schwab and key providers in the semiconductor industry, Taiwan Semiconductor and ASML.
Via The Motley Fool · April 18, 2026
This episode covers financial results from Goldman Sachs, plus an update on the U.S. blockade in the Strait of Hormuz and a listener question regarding SpaceX’s upcoming IPO.
Via The Motley Fool · April 18, 2026
Multiple reports reveal that increasing tensions in the Middle East could spell trouble for the economy.
Via The Motley Fool · April 18, 2026
The S&P 500, Nasdaq and Russell 2000 hit new peaks while oil prices tumbled.
Via Investor's Business Daily · April 17, 2026
Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profitable stock, with a target price of $24. MiniMed produces insulin pump platforms and continuous glucose monitoring technologies, and recently gained FDA approval for its next-generation insulin pump. The global diabetes market is expected to grow significantly, making MiniMed a promising investment opportunity.
Via Benzinga · April 17, 2026
Via MarketBeat · April 17, 2026
AI's biggest players face their ultimate reality check; this earnings season will separate hype from real returns.
Via The Motley Fool · April 17, 2026
What Happened? Shares of cruise ship company Carnival (NYSE:CCL) fell 5.8% in the afternoon session after investors grew concerned about rising fuel costs an...
Via StockStory · April 16, 2026
What Happened? Shares of freight carrier Old Dominion (NASDAQ:ODFL) jumped 5.3% in the afternoon session after analysts from both Stifel and Goldman Sachs ra...
Via StockStory · April 16, 2026
What Happened? Shares of enterprise technology company Hewlett Packard Enterprise (NYSE:HPE) jumped 3.7% in the afternoon session after Goldman Sachs raised ...
Via StockStory · April 16, 2026
Shares of Dell Technologies Inc. (NASDAQ: DELL) are rising Thursday after Goldman Sachs maintained its Buy rating on the stock and raised its price target.
Via Benzinga · April 16, 2026
Tesla's Shanghai plant already builds nearly a million EVs a year. Now it could become the birthplace of mass-market humanoid robots, and investors are paying close attention.
Via Barchart.com · April 16, 2026
Investors who bought the recent stock market dip have been handsomely rewarded.
Via The Motley Fool · April 16, 2026
